ANKTESIS

What this means for you

Approved and waiting on proof of use. It will register unless the applicant drops it, and its 21 Nov 2024 filing date already counts against anyone who files later.

Record

Serial number

98865900

Mark type

Stylized text

Filed

21 Nov 2024

Published for opposition

02 Sept 2025

Attorney of record

Alicia M. Passerin

Goods and services

• Class 005 — Pharmaceuticals: Biological and pharmaceutical cell preparations for medical use in cell therapy for the treatment and prevention of oncologic diseases and disorders, immune-oncologic diseases and disorders, cancer, non-cancerous neoplasia, immunologic dysfunction, immunologic-related diseases, infections, and infectious diseases
• Class 044 — Medical, beauty and agricultural services: Medical services; medical information; providing a website featuring medical information in the fields of immunotherapy, oncology, cancer, immune-oncology, autoimmune diseases, infectious diseases and human diseases; providing medical information relating to immunotherapy, oncology, cancer, immune-oncology, autoimmune diseases, infectious diseases and human diseases

Owner

• ImmunityBio, Inc., San Diego, CA, US
• ImmunityBio, Inc., San Diego, CA, US

Prosecution history

• 28 Oct 2025 — NOA E-MAILED - SOU REQUIRED FROM APPLICANT
• 02 Sept 2025 — OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
• 02 Sept 2025 — PUBLISHED FOR OPPOSITION
• 27 Aug 2025 — NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
• 04 Aug 2025 — APPROVED FOR PUB - PRINCIPAL REGISTER
• 04 Aug 2025 — EXAMINER'S AMENDMENT ENTERED
• 04 Aug 2025 — NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
• 04 Aug 2025 — EXAMINERS AMENDMENT E-MAILED
• 04 Aug 2025 — EXAMINERS AMENDMENT -WRITTEN
• 15 May 2025 — NOTIFICATION OF PRIORITY ACTION E-MAILED
• 15 May 2025 — PRIORITY ACTION E-MAILED
• 15 May 2025 — PRIORITY ACTION WRITTEN
• 15 May 2025 — ASSIGNED TO EXAMINER
• 26 Apr 2025 — NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
• 21 Nov 2024 — NEW APPLICATION ENTERED